Kenvue
Kenvue Inc. is a global consumer health enterprise that develops, manufactures, and distributes a wide portfolio of well-known everyday personal care and wellness brands. The company operates through three primary business segments, covering Self Care, Skin Health and Beauty, and Essential Health product lines. Its principal product offerings include widely recognized over-the-counter medicines, specialized skin care formulations, baby care items, wound management goods, and oral hygiene products sold to retail consumers worldwide. Revenue is primarily driven by mass retail sales through pharmacies, supermarkets, e-commerce platforms, and convenience stores across international markets. As one of the largest pure-play consumer health companies globally, the enterprise commands significant market share in personal healthcare categories. Headquartered in Skillman, New Jersey, Kenvue Inc. is publicly listed on the New York Stock Exchange under the ticker symbol KVUE.
38 of the funds FundTelligence covers report a position in Kenvue.
- Legal name
- Kenvue Inc.
- Sector
- Consumer Staples
- Country
- United States
- Funds holding it
- 38
Funds holding Kenvue
- Franklin Alt Strats — Franklin Templeton · 0.92 % (partially disclosed portfolio, September 2026)
- Storebrand Global Plus — Storebrand · 0.16 % (full portfolio disclosed, October 2026)
- Schroder ISF Global Bond — Schroders · 0.15 % (full portfolio disclosed, June 2026)
- Storebrand USA Plus — Storebrand · 0.15 % (full portfolio disclosed, October 2026)
- Handelsbanken USA Index Criteria — Handelsbanken · 0.15 % (full portfolio disclosed, October 2026)
- Storebrand US Plus — Storebrand · 0.13 % (full portfolio disclosed, October 2026)
- KLP Obligasjon Global 3 år — KLP · 0.11 % (full portfolio disclosed, June 2026)
- KLP Obligasjon Global — KLP · 0.08 % (partially disclosed portfolio, June 2026)
Showing the 8 largest of 38 funds holding it.